CLGN — Collplant Biotechnologies Share News
0.000.00%
Last trade - 00:00- $8.31m
- $5.75m
- $2.37m
Brief: Collplant Biotechnologies Announces Date For Second Quarter Financial Results
Brief: Collplant Biotechnologies Announces European Patent Allowance Secured For Its Collagen-Based Formulations Usable As Soft Tissue Fillers And Implants
Brief: CollPlant Biotechnologies Announces $3.6 Million Registered Direct Offering
Brief: CollPlant Biotechnologies Provides Corporate Update
Brief: CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
Brief: CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
Brief: Collplant Biotechnologies Announces Patent Granted In U.S. For Photocurable Dermal Filler
Brief: Collplant To Receive $10 Mln From Abbvie In Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement
Brief: CollPlant To Receive $10 Mln From AbbVie In Accordance With Regenerative Dermal Filler Product Collaboration Agreement
Brief: Collplant Biotechnologies Announces Q1 Financial Results For 2023, Provides Corporate Update
Brief: Collplant Biotechnologies Announces Date For 2023 First Quarter Financial Results And Conference Call Information
Brief: Collplant Biotechnologies Announces Full-Year Financial Results For 2022
Brief: CollPlant Biotechnologies Files For Mixed Shelf Of Up To $100 Mln
Brief: Collplant Biotechnologies Provides Q3 2022 Financial Results
Develop 3D Bioprinted Human Intestine Model For Drug Discovery
Brief: Collplant Biotechnologies Posts Quarterly Loss Per Share Of $0.39
Brief: Collplant Advances Its 3D Bioprinted Regenerative Breast Implants Into Porcine Study
RCS - Sustainable Capital - Sustainable Capital PLC Ratings Announcement
U.S. STOCKS ON THE MOVE-Allego, WeWork, Emclaire